Product
MMB
Aliases
CYT387, GS-0387
2 clinical trials
6 indications
Indication
Primary Myelofibrosis (PMF)Indication
Post-polycythemia Vera MyelofibrosisIndication
CancerClinical trial
A Phase 2, Open-label, Translational Biology Study of Momelotinib in Transfusion-Dependent Subjects With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)Status: Completed, Estimated PCD: 2017-07-18
Clinical trial
Extended Access of Momelotinib for Subjects With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)Status: Active (not recruiting), Estimated PCD: 2026-12-31